La Jolla Pharmaceutical Co. (NASDAQ LJPC)

Last Trade:	5.9100
Trade Time:	4:00PM ET
Change:	1.7800 (43.10%

La Jolla Pharmaceutical Co. stock continued to climb on Friday after the company reported positive results from a late stage study of Riquent, a treatment for the autoimmune disorder lupus.